Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Mem. Inst. Oswaldo Cruz ; 115: e190405, 2020. graf
Article in English | LILACS, BNUY, UY-BNMED | ID: biblio-1091247

ABSTRACT

BACKGROUND High-risk human papillomaviruses (HR-HPVs) are the etiological agents of cervical cancer. Among them, types 16 and 18 are the most prevalent worldwide. The HPV genome encodes three oncoproteins (E5, E6, and E7) that possess a high transformation potential in culture cells when transduced simultaneously. In the present study, we analysed how these oncoproteins cooperate to boost key cancer cell features such as uncontrolled cell proliferation, invasion potential, and cellular redox state imbalance. Oxidative stress is known to contribute to the carcinogenic process, as reactive oxygen species (ROS) constitute a potentially harmful by-product of many cellular reactions, and an efficient clearance mechanism is therefore required. Cells infected with HR-HPVs can adapt to oxidative stress conditions by upregulating the formation of endogenous antioxidants such as catalase, glutathione (GSH), and peroxiredoxin (PRX). OBJECTIVES The primary aim of this work was to study how these oncoproteins cooperate to promote the development of certain cancer cell features such as uncontrolled cell proliferation, invasion potential, and oxidative stress that are known to aid in the carcinogenic process. METHODS To perform this study, we generated three different HaCaT cell lines using retroviral transduction that stably expressed combinations of HPV-18 oncogenes that included HaCaT E5-18, HaCaT E6/E7-18, and HaCaT E5/E6/E7-18. FINDINGS Our results revealed a statistically significant increment in cell viability as measured by MTT assay, cell proliferation, and invasion assays in the cell line containing the three viral oncogenes. Additionally, we observed that cells expressing HPV-18 E5/E6/E7 exhibited a decrease in catalase activity and a significant augmentation of GSH and PRX1 levels relative to those of E5, E6/E7, and HaCaT cells. MAIN CONCLUSIONS This study demonstrates for the first time that HPV-18 E5, E6, and E7 oncoproteins can cooperate to enhance malignant transformation.


Subject(s)
Humans , Cell Transformation, Viral/genetics , Oncogene Proteins, Viral/metabolism , DNA-Binding Proteins/metabolism , Human papillomavirus 18/metabolism , Oxidation-Reduction , Gene Expression Regulation, Neoplastic , Cell Survival , Cell Line, Tumor/virology , Cell Proliferation
2.
Clinics ; 73(supl.1): e486s, 2018. graf
Article in English | LILACS | ID: biblio-974952

ABSTRACT

Human papillomavirus infection is associated with the development of malignant and benign neoplasms. Approximately 40 viral types can infect the anogenital mucosa and are categorized into high- and low-risk oncogenic human papillomavirus, depending on their association with the development of cervical carcinoma. High-risk human papillomavirus 16 and 18 are detected in 55% and 15% of all invasive cervical squamous cell carcinomas worldwide, respectively. Low-risk human papillomavirus 6 and 11 are responsible for 90% of genital warts and are also associated with the development of recurrent respiratory papillomatosis. Human papillomavirus preferentially infects mitotic active cells of the basal layer from both mucosal and cutaneous epithelium through microabrasions. The viral life cycle synchronizes with the epithelial differentiation program, which may be due, in part, to the binding of differentially expressed cellular transcription factors to the long control region throughout the various epithelial layers. This review aimed to summarize the current knowledge regarding the mechanisms by which viral gene expression is regulated and the influence of human papillomavirus heterogeneity upon this phenomenon. A better understanding of the regulatory mechanisms may elucidate the particularities of human papillomavirus-associated pathogenesis and may provide new tools for antiviral therapy.


Subject(s)
Humans , Papillomaviridae/genetics , Transcription Factors/genetics , Gene Expression Regulation, Viral , Papillomavirus Infections/virology , Papillomaviridae/physiology , Oncogene Proteins, Viral/genetics , Promoter Regions, Genetic/genetics
3.
Clinics ; 73(supl.1): e489s, 2018. tab, graf
Article in English | LILACS | ID: biblio-952844

ABSTRACT

Cutaneous human papillomaviruses (HPVs) include β- and γ-HPVs, in addition to a small fraction of α-HPVs. β-HPVs were first isolated from patients with the rare genetic disorder Epidermodysplasia verruciformis, and they are associated with the development of nonmelanoma skin cancer at sun-exposed skin sites in these individuals. Organ transplant recipients also have greater susceptibility to β-HPV infection of the skin and an increased risk of developing nonmelanoma skin cancer. In both immunosuppressed and immunocompromised individuals, cutaneous HPVs are ubiquitously disseminated throughout healthy skin and may be an intrinsic part of the commensal flora. Functional analysis of E6 and E7 proteins of specific cutaneous HPVs has provided a mechanistic comprehension of how these viruses may induce carcinogenesis. Nevertheless, additional research is crucial to better understand the pathological implications of the broad distribution of these HPVs.


Subject(s)
Humans , Papillomaviridae/isolation & purification , Skin Neoplasms/virology , Papillomavirus Infections/epidemiology , Skin/virology , Skin Neoplasms/pathology , Skin Neoplasms/epidemiology , Epidermodysplasia Verruciformis , Prevalence , Immunocompromised Host , Papillomavirus Infections/complications , Transplant Recipients
4.
Braz. j. infect. dis ; 21(4): 376-385, July-Aug. 2017. tab, graf
Article in English | LILACS | ID: biblio-888894

ABSTRACT

Abstract The aims of this study were to determine the incidence of external genital lesions (EGLs), specifically histologically confirmed condyloma (genital warts) and Penile Intraepithelial Neoplasia (PeIN), and genital HPV infection progression to EGLs among healthy men aged 18-73 residing in Brazil. Subjects included 1118 men enrolled in the HPV Infection in Men (HIM) study between July 2005 and June 2009. At each visit, EGLs were biopsied and subjected to pathological evaluation. HPV status in genital swabs and biopsies was determined by Linear Array and INNO-LiPA, respectively. Age-specific EGLs incidence and the proportion and median time to EGL development were estimated. Kaplan-Meier cumulative incidence rates at 6, 12, and 24 months were determined. During follow-up, 73 men developed an incident EGL. Men could develop multiple EGLs and there were 36 men with condyloma, 27 men with lesions suggestive of condyloma, six men with PeIN, and 20 men with non-HPV lesions. HPV-positive men who developed EGLs were younger (p = 0.002) than men that did not develop lesions. Among the 815 men with HPV infection, 4% progressed to EGL with the same HPV detected in the swab. During follow up, 15.7% of genital HPV-6 and HPV-11 infections progressed to condyloma (median progression time of nine months for HPV-6 versus 6.8 months for HPV-11). Approximately 1% of HPV-16 infections progressed to PeIN with a median progression time of 25 months. HPV types covered by the 4-valent HPV vaccine were detected in 82.3% and 83.3% of condyloma and PeIN, respectively. The high burden of HPV and high frequency of progression to disease underscores the need to offer HPV prophylactic vaccination to men to reduce the overall burden of infection and diseases caused by HPV.


Subject(s)
Humans , Male , Adolescent , Adult , Middle Aged , Aged , Young Adult , Papillomaviridae/genetics , Penile Diseases/epidemiology , Condylomata Acuminata/epidemiology , Papillomaviridae/classification , Penile Diseases/diagnosis , Penile Diseases/virology , Brazil/epidemiology , Condylomata Acuminata/diagnosis , Condylomata Acuminata/virology , Incidence , Disease Progression , Genotype
5.
In. Lopes, Ademar; Chammas, Roger; Iyeyasu, Hirofumi. Oncologia para a graduação. São Paulo, Lemar, 3; 2013. p.62-69, tab. (Oncologia para a graduação).
Monography in Portuguese | LILACS | ID: lil-691980
6.
In. Coelho, Francisco Ricardo Gualda; Soares, Fernando Augusto; Foch, José; Fregnani, José Humberto Tavares Guerreiro; Zeferino, Luiz Carlos; Villa, Luisa Lina; Federico, Miriam Honda; Novaes, Paulo Eduardo Ribeiro dos Santos; Costa, Ronaldo Lúcio Rangel. Câncer do colo do útero. São Paulo, Tecmedd, 2008. p.58-66, ilus, tab.
Monography in Portuguese | LILACS | ID: lil-494635
7.
Medicina (B.Aires) ; 62(3): 209-220, 2002. ilus, mapas, tab
Article in Spanish | LILACS | ID: lil-318149

ABSTRACT

Human Papillomaviruses (HPVs) are etiologically associated to cervical carcinoma. In order to evaluate HPV infection and its relationship with the high frequency of this neoplasia in Quechua women from Jujuy (Argentina), 271 cervical samples from preneoplastic and neoplastic lesions (biopsies) and normal controls (cytologies) were studied. Detection and typing were performed using PCR-RFLP or PCR-hybridization and the HPV-16 variability in L1 and E6 genes (by PCR-hybridization) was analysed. HPV was detected in 52 of controls, 91 of low-grade lesions, 97 of high-grade lesions and 100 of invasive carcinomas, corresponding 55 to HPV-16. HPV-16 European variants were predominant, most of them being non-prototypic strains. The high frequency of high risk infection types and the raised proportion of HPV-16 non-prototypic variants related to a greater oncogenic potential could explain, in part, the high cervical cancer frequency of this native population. These data may contribute to disease control and vaccinal formulation


Subject(s)
Humans , Female , Adolescent , Adult , Middle Aged , Genetic Variation , Papillomaviridae , Papillomavirus Infections/epidemiology , Tumor Virus Infections , Uterine Cervical Neoplasms , Argentina , Base Sequence , Incidence , Nucleic Acid Hybridization , Papillomaviridae , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Prevalence , Papillomavirus Infections/genetics , Tumor Virus Infections , Uterine Cervical Neoplasms
SELECTION OF CITATIONS
SEARCH DETAIL